MedPath

Treatment of Type 2 Diabetes with Unani formulatio

Phase 2
Conditions
Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs
Registration Number
CTRI/2023/09/057695
Lead Sponsor
Central Council for Research in Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The patients diagnosed with Type II diabetes, and having a Fasting Blood Sugar of 126 – 175mg/ 100ml and Post Prandial Blood Sugar of 200-250mg/100ml and HbA1C above 6.5 - 8 and Subjects without diabetes for controls.

Exclusion Criteria

Exclusion criteria for patients and controls:-

The Subjects who are unwilling to give the blood sample.

Pregnant women, lactating women, cancer patients and mentally disorder people

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath